Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transgenic mouse model for central nervous system demyelination.

T Yoshioka1, L Feigenbaum, G Jay

  • 1Laboratory of Virology, Jerome H. Holland Laboratory, American Red Cross, Rockville, Maryland 20855.

Molecular and Cellular Biology
|November 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Activated c-Kit receptor in the heart promotes cardiac repair and regeneration after injury.

Cell death & disease·2016
Same author

Enhanced T-cell activation and differentiation in lymphocytes from transgenic mice expressing ubiquitination-resistant 2KR LAT molecules.

Gene therapy·2015
Same author

Lacosamide cardiac safety: clinical trials in patients with partial-onset seizures.

Acta neurologica Scandinavica·2015
Same author

The hiv tat gene is a promoter of epidermal skin tumors.

International journal of oncology·2011
Same author

Synergism between the hbx gene and aflatoxin B-1 in the development of murine liver-cancer.

International journal of oncology·2011
Same author

Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas.

Oncogene·2007

Major Histocompatibility Complex (MHC) class I gene targeting in oligodendrocytes caused demyelination in mice, suggesting a direct role in disease. This finding indicates infectious agents may trigger demyelinating diseases.

Area of Science:

  • Neuroimmunology
  • Molecular Biology
  • Genetics

Background:

  • Demyelinating diseases like multiple sclerosis show elevated Major Histocompatibility Complex (MHC) antigen expression.
  • The precise role of MHC antigens in initiating demyelination is not fully understood.

Purpose of the Study:

  • To investigate the direct role of MHC class I antigens in demyelination.
  • To explore the potential mechanisms by which MHC class I might induce demyelinating pathology.

Main Methods:

  • Generation of transgenic mice with targeted syngeneic MHC class I gene expression in oligodendrocytes.
  • Observation and analysis of neurological and pathological phenotypes in the generated mouse model.

Main Results:

Related Experiment Videos

  • Transgenic mice developed severe tremors, tonic seizures, and extensive demyelination in the brain and spinal cord.
  • Demyelination occurred without immune cell infiltration, supporting a non-autoimmune mechanism.

    • Conclusions:

    • MHC class I antigen expression in oligodendrocytes can directly induce demyelination.
    • Infectious agents, potentially viruses, may trigger demyelinating diseases by activating MHC gene expression in oligodendroglia.